Principal Investigators

Benjamin G. Neel, MD, PhD
Professor of Medicine, NYU School of Medicine
Director, Laura and Isaac Perlmutter Cancer Center
contact :


Toshiyuki Araki, PhD Toshi Araki
Research Assistant Professor
Ph.D., 2000, Protein Research Institute, Suita Japan
My work focuses on the Role of RAS/ERK signaling in human development and cancers.
contact :

Post Doctoral Fellows

Abhishek Bhardwaj
Post-Doctoral Fellow
Ph.D., 2016, National Institute of Immunology, JNU, New Delhi/ India
Investigating the role of PTP1B  in regulating RNF213, the identification and function of RNF213 substrates and the detailed mechanism of RNF213 ubiquitin ligase activity.
contact :

Mitchell Geer
Post-Doctoral Fellow
Ph.D., 2017, University of Birmingham, UK
I am studying kinase-phosphatase mediated signaling in leukemia development, particularly the role of specific ERK isoforms in normal hematopoiesis and myeloproliferative disorders.
contact :

Jayu Jen
Post-Doctoral Fellow
Ph.D., 2015, National Cheng Kung University, Tainan, Taiwan
I am studying autophagy-mediated tumor progression and tumor microenvironment modulation.
contact :

Suman Mukhopadhyay
Post-Doctoral Fellow
Ph.D., 2015, CUNY Graduate Center, City University of New York, USA
Post-Doctoral Fellow
NCI RAS Initiative, Frederick National Laboratory for Cancer Research
I am studying the mechanisms of response and resistance to KRAS, SHP2 inhibitors in lung cancer.

Oscar Pundel
Post-Doctoral Fellow
PhD, Biophysics, Queen Mary University of London
M.Sc Biochemistry Ecole Polytechnique Fédérale de Lausanne
B.Sc Chemistry Ecole Polytechnique Fédérale de Lausanne
My work focuses around the generation of novel high grade serous ovarian cancer organoid models and their study in genetic instability, 3D chromatin architecture and immune regulation in syngeneic mice models.

Kwan Ho Tang
Ph.D., 2013, Chinese Academy of Science, Beijing, China
Post-Doctoral Fellow
Ph.D., University of Hong Kong
I am studying the effects of SHP2 inhibitors on the tumor microenvironment in lung and pancreas cancer, and also using scRNAseq to define cellular hieracrchies in normal fallopian tube and ovarian cancer.
contact :


Wei Wei
Graduate Student
MS of Biology from NYU, 2014
I studying mechanisms of cancer cell resistance to SHP2 inhibitors.
contact :

Connor Foster
MD/PhD Student
BA in Biological Sciences from Cornell University, 2015
I study the role of PZR in the immune system as well as the role of shp2 binding proteins in downregulating the immune response in cancer.

Laboratory Manager

Kiyomi Araki, Ph.D.
contact :